170 related articles for article (PubMed ID: 37704199)
1. CROI 2023: Metabolic and Other Complications of HIV Infection.
Sarkar S; Brown TT
Top Antivir Med; 2023 Jun; 31(4):538-542. PubMed ID: 37704199
[TBL] [Abstract][Full Text] [Related]
2. CROI 2021: Metabolic and Other Complications of HIV Infection or COVID-19.
Sarkar S; Brown TT
Top Antivir Med; 2021; 29(2):328-333. PubMed ID: 34107202
[TBL] [Abstract][Full Text] [Related]
3. CROI 2022: metabolic and other complications of HIV infection or COVID-19.
Sarkar S; Brown TT
Top Antivir Med; 2022; 30(3):522-527. PubMed ID: 36347058
[TBL] [Abstract][Full Text] [Related]
4. CROI 2021: Neurologic Complications of HIV-1 Infection or COVID-19.
Ances BM; Anderson AM; Letendre SL
Top Antivir Med; 2021; 29(2):334-343. PubMed ID: 34107203
[TBL] [Abstract][Full Text] [Related]
5. CROI 2023: Neuropsychiatric Complications in People With HIV.
Anderson AM; Ances BM; Letendre SL
Top Antivir Med; 2023 Jun; 31(4):543-555. PubMed ID: 37704201
[TBL] [Abstract][Full Text] [Related]
6. CROI 2016: Complications of HIV Infection and Antiretroviral Therapy.
Havlir DV; Currier JS
Top Antivir Med; 2016; 24(1):38-46. PubMed ID: 27398861
[TBL] [Abstract][Full Text] [Related]
7. CROI 2015: Basic Science Review.
Stevenson M
Top Antivir Med; 2015; 23(1):4-7. PubMed ID: 25965308
[TBL] [Abstract][Full Text] [Related]
8. CROI 2015: Complications of HIV Infection and Antiretroviral Therapy.
Havlir DV; Currier JS
Top Antivir Med; 2015; 23(1):56-65. PubMed ID: 25965312
[TBL] [Abstract][Full Text] [Related]
9. Selected highlights from the 6th Conference on Retroviruses and Opportunistic Infections.
Bartnof HS
BETA; 1999 Apr; 12(2):33-52. PubMed ID: 11366695
[TBL] [Abstract][Full Text] [Related]
10. Women in HIV conference research: trends and content analysis of abstracts presented at 17 HIV/AIDS conferences from 2003 to 2010.
Lunny C; Shearer BD; Cruikshank J; Thomas K; Smith A
Womens Health Issues; 2011; 21(6):407-17. PubMed ID: 21890378
[TBL] [Abstract][Full Text] [Related]
11. CROI 2018: Complications of HIV Infection and Antiretroviral Therapy.
Currier JS; Havlir DV
Top Antivir Med; 2018 May; 26(1):22-29. PubMed ID: 29727294
[TBL] [Abstract][Full Text] [Related]
12. Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). February 22-25, 2005. Complications/toxicity of HIV therapy.
Moore RD; Cofrancesco J
HIV Clin Trials; 2005; 6(4):229-34. PubMed ID: 16214738
[No Abstract] [Full Text] [Related]
13. A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).
Rabasseda X
Drugs Today (Barc); 2015 Mar; 51(3):209-16. PubMed ID: 25876564
[TBL] [Abstract][Full Text] [Related]
14. CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment.
Currier JS; Havlir DV
Top Antivir Med; 2017; 25(2):77-83. PubMed ID: 28598792
[TBL] [Abstract][Full Text] [Related]
15. Progressive resistive exercise interventions for adults living with HIV/AIDS.
O'Brien K; Nixon S; Glazier RH; Tynan AM
Cochrane Database Syst Rev; 2004 Oct; (4):CD004248. PubMed ID: 15495092
[TBL] [Abstract][Full Text] [Related]
16. CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy.
Luetkemeyer AF; Havlir DV; Currier JS
Top Antivir Med; 2013; 21(2):62-74. PubMed ID: 23681961
[TBL] [Abstract][Full Text] [Related]
17. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). Complications of antiretroviral therapies and HIV.
Keruly J
Hopkins HIV Rep; 2004 Mar; 16(2):10-1. PubMed ID: 15119311
[No Abstract] [Full Text] [Related]
18. CROI 2014: Advances in antiretroviral therapy.
Taylor BS; Shalev N; Wilkin TJ
Top Antivir Med; 2014 May; 22(2):616-31. PubMed ID: 24901887
[TBL] [Abstract][Full Text] [Related]
19. Conference on retroviruses and opportunistic infections (virtual): March 6-10, 2021.
Messin LJ
EBioMedicine; 2021 Jun; 68():103428. PubMed ID: 34139431
[TBL] [Abstract][Full Text] [Related]
20. CROI 2022: summary of basic science research in HIV and SARS-CoV-2.
Stevenson M
Top Antivir Med; 2022; 30(2):419-425. PubMed ID: 36346700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
